Greenwich Lifesciences Inc

1. 1

   Election of Five Directors

   ManagementBoard: FOR

   Elect David B. McWilliams, Snehal S. Patel, Eric Rothe, F. Joseph Daugherty, and Kenneth Hallock to serve until the 2027 Annual Meeting.

2. 2

   Ratification of Appointment of MaloneBailey LLP

   ManagementBoard: FOR

   Ratify the Audit Committee and Board’s appointment of MaloneBailey LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

3. 3

   Advisory Vote to Approve Executive Compensation

   ManagementBoard: FOR

   Approve, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the proxy statement, including the compensation tables and narrative disclosure.

   More detail

   Proposal 3 asks stockholders to approve, on a non-binding advisory basis, the compensation paid to Greenwich LifeSciences’ named executive officers. The resolution covers the compensation disclosures required under Item 402 of Regulation S-K, including the compensation tables and accompanying narrative. The filing explains that the vote is intended to provide stockholders with an opportunity to express their views on overall executive compensation rather than on any individual pay element. Management presents the compensation program as intended to attract, retain, and motivate talented executives. It also states that the program is designed to align executive interests with those of stockholders. The proxy directs stockholders to review the executive-compensation section, including the Summary Compensation Table and related disclosures for fiscal 2025. The vote is advisory and therefore will not bind the Board or Compensation Committee, overturn prior decisions, or create an additional fiduciary duty. Nevertheless, the Board and Compensation Committee state that they value stockholder views and will consider the result in future compensation decisions. Approval requires a majority of the voting power present and entitled to vote, with abstentions and broker non-votes having the same effect as votes against. The Board recommends a vote FOR the proposal.

4. 4

   Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation

   ManagementBoard: FOR

   Indicate whether future advisory votes on named executive officer compensation should occur every one, two, or three years, or whether the stockholder should abstain.

   More detail

   Proposal 4 asks stockholders to express a non-binding preference for how often the Company should hold future advisory votes on named executive officer compensation. The available choices are every year, every two years, every three years, or abstention. The proposal implements the periodic “say-on-frequency” vote contemplated by Section 14A of the Exchange Act and related SEC rules. The Board recommends holding the advisory compensation vote every three years. Management states that a triennial schedule would allow stockholders to provide direct input on the Company’s compensation philosophy, policies, and practices while maintaining effective communication. The recommendation follows the Board’s consideration of the benefits and consequences of each available alternative. The resolution makes clear that stockholders are selecting a preferred frequency rather than approving or rejecting the Board’s recommendation. The frequency receiving the greatest number of votes cast will be considered the stockholders’ preferred frequency. Because the vote is advisory, the result will not bind the Board or the Company, which may ultimately choose a different schedule. The proposal is distinct from the advisory vote approving executive compensation under Proposal 3 and concerns only the timing of future votes.

Upcoming shareholder meetings at Greenwich Lifesciences Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Greenwich Lifesciences Inc 2026 annual meeting?

Greenwich Lifesciences Inc (GLSI) holds its 2026 annual shareholder meeting on Friday, December 18, 2026.

What is the record date for the Greenwich Lifesciences Inc 2026 meeting?

The record date for the Greenwich Lifesciences Inc 2026 meeting is Monday, October 26, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Greenwich Lifesciences Inc's 2026 meeting?

The board is presenting 5 director nominees at the Greenwich Lifesciences Inc 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Greenwich Lifesciences Inc 2026 meeting?

Shareholders will vote on 4 proposals at the Greenwich Lifesciences Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.